Acta Neurol Scand Suppl. 1989;126:183-7.

Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).

Source

Birkmayer Institute for Parkinson Therapy, Vienna, Austria.

Abstract

The coenzyme nicotinamide adenine dinucleotide (NADH) has been used as a novel medication in 161 Parkinson patients in an open label trial. In all but 18 patients (11.2%) an improvement in their disability was observed. 115 patients (71.4%) showed a very good (better than 30%) response, and 28 patients (17.4%) a moderate response up to 30%. The best results were obtained with a dose of 25 to 50 mg every second day by i.v. administration. Concomitantly with the improvement in disability, the urine HVA level increased significantly, indicating a stimulation of endogenous L-DOPA biosynthesis. 8 patients have been treated with nicotinamide adenine dinucleotidephosphate (NADPH), 5 of whom exhibited an improvement in their disability from 35 to 55%. The other 3 showed a moderate response of 20 to 25%. In all these patients an increase in the urine level of HVA was detected, reflecting elevated endogenous L-DOPA production.

PMID:: 2618590; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Medical

Parkinson's Disease - MedlinePlus Health Information

Molecular Biology Databases

LEVODOPA - HSDB

Supplemental Content

Save items

Related citations in PubMed

Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease. [Ann Clin Lab Sci. 1989]
Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease.
Birkmayer W, Birkmayer GJ. Ann Clin Lab Sci. 1989 Jan-Feb; 19(1):38-43.
The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. [J Neural Transm Park Dis Demen...]
The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients.
Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E. J Neural Transm Park Dis Dement Sect. 1989; 1(4):297-302.
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. [J Neural Transm. 1996]
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
Kuhn W, Müller T, Winkel R, Danielczik S, Gerstner A, Häcker R, Mattern C, Przuntek H. J Neural Transm. 1996; 103(10):1187-93.
Review Is NADH effective in the treatment of Parkinson's disease? [Drugs Aging. 1998]
Review Is NADH effective in the treatment of Parkinson's disease?
Swerdlow RH. Drugs Aging. 1998 Oct; 13(4):263-8.
Review Treatment of Parkinson's disease: levodopa as the first choice. [J Neurol. 2002]
Review Treatment of Parkinson's disease: levodopa as the first choice.
Katzenschlager R, Lees AJ. J Neurol. 2002 Sep; 249 Suppl 2:II19-24.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy o...
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).
Acta Neurol Scand Suppl. 1989 ;126:183-7.

PubMed
Comparison of home and hospital care of advanced cancer patients.
Comparison of home and hospital care of advanced cancer patients.
Tumori. 1989 Dec 31 ;75(6):619-25.

PubMed
The further application of MTT-formazan colorimetry to studies on filarial worm ...
The further application of MTT-formazan colorimetry to studies on filarial worm viability.
Trop Med Parasitol. 1989 Sep ;40(3):311-6.

PubMed
[Campylobacter pylori in endoscopic biopsies of the gastric antrum and its assoc...
[Campylobacter pylori in endoscopic biopsies of the gastric antrum and its association with chronic gastritis].
Rev Gastroenterol Mex. 1989 Oct-Dec ;54(4):207-11.

PubMed
Similarities between cysteinesulphinate transaminase and aspartate aminotransfer...
Similarities between cysteinesulphinate transaminase and aspartate aminotransferase.
Ciba Found Symp. 1979 ;(72):259-70.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: